STAT1 GAIN-OF-FUNCTION DISEASE

Clinical trials for STAT1 GAIN-OF-FUNCTION DISEASE explained in plain language.

Never miss a new study

Get alerted when new STAT1 GAIN-OF-FUNCTION DISEASE trials appear

Sign up with your email to follow new studies for STAT1 GAIN-OF-FUNCTION DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Experimental drug offered to single patient with rare immune disease

Disease control AVAILABLE

This expanded access program provides itacitinib, an experimental drug, to one patient with STAT1 gain-of-function disease who also has aplastic anemia. The goal is to control the overactive immune system and manage the disease. This is not a cure, and the patient will likely nee…

Matched conditions: STAT1 GAIN-OF-FUNCTION DISEASE

Sponsor: Incyte Corporation • Aim: Disease control

Last updated Jun 15, 2026 18:57 UTC

STAT1 GAIN-OF-FUNCTION DISEASE

Get alerted when new STAT1 GAIN-OF-FUNCTION DISEASE trials appear

Experimental drug offered to single patient with rare immune disease